ASCO 2010非小细胞肺癌研究进展

2010 ASCO Annual Meeting: Progress in the Studies of Non-small Cell Lung Cancer

非小细胞肺癌治疗领域一直备受关注。2010年美国临床肿瘤学年会(ASCO)上公布的研究提示,硒剂化学预防未获成功,新辅助化疗的远期获益仍存疑问,分子靶向治疗也未能在患者生存方面有所改善。尽管结果是阴性,但仍给我们带来许多启示。

The field of non-small cell lung cancer treatment has attracted great attention. The studies announced in 2010 ASCO Annual Meeting suggest that chemopreventive agent selenium has not been successful, the long-term benefits of neoadjuvant chemotherapy are still in doubt, and molecular targeted therapy has showed no improvement in the survival of the patients. The studies in non-small cell lung cancer treatment still have a long way to go.